Nanoparticles must possess specific features tailored to their application area, with consistent characteristics across study batches. Monodispersity and colloidal stability are crucial for metal or metal oxide nanoparticles, requiring surface stabilizers to prevent aggregation. This study addresses the challenge of functionalizing surfactant- coated inorganic nanoparticles for biomedical use, hindered by excess unbound surfactant. Bioconjugation limitations arise from equilibrium between free molecules and those bound to nanoparticle surfaces, impacting in vitro and in vivo biocompatibility. Testing common surfactants like monothiolated polyethylene glycol and amphiphilic polymers, dodecylamine-grafted-poly(isobutylene-alt-maleic-anhydride), revealed insufficient affinity, leading to loss of colloidal stability as excess surfactant is removed. In contrast, newly introduced multidentate surfactants exhibit high avidity, excelling in maintaining stability and suggesting improvements in various nanoparticle applications. The introduction of these polymers addresses biocompatibility issues in the human system where excess stabilizing ligands, post- inorganic nanoparticle synthesis, exceed tolerability, necessitating the removal of excess surfactant despite destabilizing the samples.
Giustra, M., Arrigoni, F., Novati, B., Garbujo, S., Salvioni, L., Colombo, A., et al. (2024). Multidentate surfactants for improving stability and biological properties. Intervento presentato a: NANOMIB Conference. Recent Advances in Nanomedicine: Opportunities and Challenges, Milano.
Multidentate surfactants for improving stability and biological properties
Marco Giustra
Primo
;Federica Arrigoni;Brian Novati;Stefania Garbujo;Lucia Salvioni;Alessandro Colombo;Luca Bertini;Luca De Gioia;Miriam Colombo
2024
Abstract
Nanoparticles must possess specific features tailored to their application area, with consistent characteristics across study batches. Monodispersity and colloidal stability are crucial for metal or metal oxide nanoparticles, requiring surface stabilizers to prevent aggregation. This study addresses the challenge of functionalizing surfactant- coated inorganic nanoparticles for biomedical use, hindered by excess unbound surfactant. Bioconjugation limitations arise from equilibrium between free molecules and those bound to nanoparticle surfaces, impacting in vitro and in vivo biocompatibility. Testing common surfactants like monothiolated polyethylene glycol and amphiphilic polymers, dodecylamine-grafted-poly(isobutylene-alt-maleic-anhydride), revealed insufficient affinity, leading to loss of colloidal stability as excess surfactant is removed. In contrast, newly introduced multidentate surfactants exhibit high avidity, excelling in maintaining stability and suggesting improvements in various nanoparticle applications. The introduction of these polymers addresses biocompatibility issues in the human system where excess stabilizing ligands, post- inorganic nanoparticle synthesis, exceed tolerability, necessitating the removal of excess surfactant despite destabilizing the samples.File | Dimensione | Formato | |
---|---|---|---|
Giustra-2024-NANOMIB Conference.pdf
Solo gestori archivio
Descrizione: Intervento a convegno - Abstract
Tipologia di allegato:
Other attachments
Licenza:
Tutti i diritti riservati
Dimensione
69.13 kB
Formato
Adobe PDF
|
69.13 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.